CCMW
GILD icon

Cypress Capital Management (Wyoming)’s Gilead Sciences GILD Stock Holding History

Cypress Capital Management (Wyoming)’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5
Closed -$419 – 153
2024
Q3 		$419 Hold
5
– – ﹤0.01% 153
2024
Q2 		$343 Hold
5
– – ﹤0.01% 158
2024
Q1 		$366 Buy
+5
New +$384 ﹤0.01% 162
2022
Q3 		– Sell
-50
Closed -$3K – 161
2022
Q2 		$3K Sell
50
-100
-67% -$6.19K ﹤0.01% 146
2022
Q1 		$9K Hold
150
– – 0.01% 130
2021
Q4 		$11K Hold
150
– – 0.01% 181
2021
Q3 		$10K Hold
150
– – 0.01% 173
2021
Q2 		$10K Sell
150
-4,236
-97% -$283K 0.01% 222
2021
Q1 		$283K Sell
4,386
-237
-5% -$15.3K 0.25% 66
2020
Q4 		$269K Sell
4,623
-3,454
-43% -$208K 0.23% 67
2020
Q3 		$516K Sell
8,077
-8
-0.1% -$555 0.46% 45
2020
Q2 		$622K Buy
8,085
+7,975
+7,250% +$611K 0.62% 44
2020
Q1 		$8K Buy
+110
New +$7.6K 0.01% 141
2019
Q1 		– Sell
-350
Closed -$22K – 299
2018
Q4 		$22K Sell
350
-825
-70% -$57.7K 0.04% 172
2018
Q3 		$91K Buy
1,175
+1,075
+1,075% +$81.2K 0.09% 132
2018
Q2 		$7K Hold
100
– – 0.01% 280
2018
Q1 		$8K Hold
100
– – 0.01% 254
2017
Q4 		$7K Hold
100
– – 0.01% 266
2017
Q3 		$8K Hold
100
– – 0.01% 220
2017
Q2 		$7.08K Hold
100
– – 0.01% 220
2017
Q1 		$6.79K Sell
100
-22,287
-100% -$1.57M 0.01% 223
2016
Q4 		$1.64M Sell
22,387
-9,645
-30% -$717K 1.73% 13
2016
Q3 		$2.53M Sell
32,032
-700
-2% -$56.9K 3.24% 6
2016
Q2 		$2.73M Sell
32,732
-5,077
-13% -$451K 3.57% 7
2016
Q1 		$3.47M Buy
37,809
+4,790
+15% +$432K 4.69% 6
2015
Q4 		$3.34M Hold
33,019
– – 4.2% 7
2015
Q3 		$3.24M Sell
33,019
-2,430
-7% -$270K 4.16% 7
2015
Q2 		$4.15M Buy
35,449
+2,330
+7% +$255K 4.69% 4
2015
Q1 		$3.25M Buy
33,119
+8,075
+32% +$820K 3.98% 5
2014
Q4 		$2.36M Buy
+25,044
New +$2.59M 3.07% 6

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cypress Capital Management (Wyoming)'s GILD Position: Q4 2024 in Review

Cypress Capital Management (Wyoming) sold out of Gilead Sciences (GILD) in Q4 2024, closing a stake of 5 shares — an estimated $419 sold.

Cypress Capital Management (Wyoming) first reported a position in GILD in Q4 2014 and held it in 30 quarters. The position peaked at $4.15M in Q2 2015. 1,888 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

  • Cypress Capital Management (Wyoming) reported no remaining Gilead Sciences position as of Q4 2024 after selling out during the quarter.
  • Cypress Capital Management (Wyoming) sold 5 Gilead Sciences shares in Q4 2024, an estimated $419.
  • Cypress Capital Management (Wyoming) first reported a position in Gilead Sciences in Q4 2014 and held it in 30 quarters.
  • Cypress Capital Management (Wyoming)'s Gilead Sciences position peaked at $4.15M in Q2 2015.
  • 1,888 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on Cypress Capital Management (Wyoming)'s 13F filing for Q4 2024, filed 23 Jan 2025.